People · Operator
Named in public records as an officer, director or promoter · active 2015–2015 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Alterix Inc. | — | Pharmaceuticals | Series A | $4.3M | $131.6M | 2015 |
Janice D. DiPietro, D.B.A. at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Janice D. DiPietro, D.B.A. on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Galen D. Grayson, M.D. | 1 | 1 |
| Harry G. McCoy, Pharm.D. | 1 | 1 |
| John J. Clark Jr. | 1 | 1 |
| Frank A. Manguso | 1 | 1 |
| Patrick T. Mooney, M.D. | 1 | 1 |
| David R. Staskin, M.D. | 1 | 1 |
| Frederic J. De Bure | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.